Aditya Birla Sun Life AMC Limited (BOM:543374)

Inozyme Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	245,011	183,681	131,082	89,626	153,749	-
Market Cap Growth	26.73%	40.13%	46.26%	-41.71%	-	-
Enterprise Value	209,277	183,409	131,051	89,206	153,319	-
Last Close Price	846.40	620.41	434.19	293.43	488.42	-
PE Ratio	25.21	19.74	16.80	15.03	22.85	-
PS Ratio	11.86	9.27	8.01	6.64	10.94	-
PB Ratio	6.57	4.93	4.14	3.56	7.00	-
P/TBV Ratio	6.60	4.95	4.15	3.58	7.04	-
P/FCF Ratio	-	27.12	20.04	21.42	28.12	-
P/OCF Ratio	-	25.93	19.14	20.49	27.30	-
EV/Sales Ratio	10.13	9.25	8.01	6.61	10.91	-
EV/EBITDA Ratio	15.49	14.49	12.79	11.07	16.93	-
EV/EBIT Ratio	15.88	14.67	12.93	11.19	17.08	-
EV/FCF Ratio	-	27.08	20.03	21.32	28.04	-
Debt / Equity Ratio	0.02	0.02	0.03	0.02	0.03	0.04
Debt / EBITDA Ratio	0.05	0.05	0.08	0.06	0.06	0.08
Debt / FCF Ratio	-	0.10	0.12	0.12	0.10	0.12
Asset Turnover	-	0.52	0.52	0.52	0.64	0.68
Quick Ratio	-	17.22	17.78	14.34	14.52	8.65
Current Ratio	-	17.70	18.29	15.14	15.02	8.85
Return on Equity (ROE)	-	26.99%	27.45%	25.30%	34.49%	34.84%
Return on Assets (ROA)	-	20.52%	20.14%	19.07%	25.39%	24.54%
Return on Capital (ROIC)	23.39%	22.19%	21.79%	20.69%	27.94%	27.77%
Return on Capital Employed (ROCE)	-	32.10%	30.50%	30.40%	39.20%	39.10%
Earnings Yield	3.97%	5.07%	5.95%	6.65%	4.38%	-
FCF Yield	-	3.69%	4.99%	4.67%	3.56%	-
Dividend Yield	2.84%	3.87%	3.11%	3.49%	2.34%	-
Payout Ratio	-	41.80%	19.38%	52.40%	34.46%	26.60%
Buyback Yield / Dilution	-0.15%	-0.14%	-0.00%	0.02%	-0.29%	-
Total Shareholder Return	2.69%	3.72%	3.10%	3.52%	2.05%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.